Sharekhan

IOL Chemicals and Pharmaceuticals Ltd

Fri 29/08/2025,15:55:44 NSE: IOLCP

₹ 90.74 -0.17 (-0.19%)
BUY NOW Buy IOL Chemicals and Pharmaceuticals Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock IOL Chemicals and Pharmaceuticals Ltd

Fri 29/08/2025,16:1:0

IOL Chemicals and Pharmaceuticals Ltd

Fri 29/08/2025,15:55:44 | NSE : IOLCP

₹ 90.74-0.17 (-0.19%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 91.36

Previous Close

₹ 90.91

Volume

533519

Mkt Cap ( Rs. Cr)

₹2663.47

High

₹ 92.80

Low

₹ 90.35

52 Week High

₹ 107.54

52 Week Low

₹ 57.50

Book Value Per Share

₹ 56.53

Dividend Yield

0.88

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on IOL Chemicals and Pharmaceuticals Ltd

Your Vote -

Buy

62.95%

Hold

1.92%

Sell

35.13%

62.95%

780 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

90.74

351

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

351

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts IOL Chemicals and Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • IOL Chemicals and Ph - Shareholders meeting

    22 Aug 2025, 5:20PM Submission of Voting Results along with Scrutinizer s Report with regard to the 38th Annual General Meeting of the Company

  • IOL Chemicals and Ph - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    22 Aug 2025, 5:11PM Voting Results along with Scrutinizer's Report with regard to the 38th Annual General Meeting

  • IOL Chemicals and Ph - Shareholders meeting

    22 Aug 2025, 4:58PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 22, 2025

  • IOL Chemicals and Ph - Shareholder Meeting / Postal Ballot-Outcome of AGM

    22 Aug 2025, 4:56PM Proceedings of 38th Annual General Meeting

  • IOL Chemicals and Ph - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    22 Aug 2025, 5:11PM Voting Results along with Scrutinizer's Report with regard to the 38th Annual General Meeting

  • IOL Chemicals and Ph - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    22 Aug 2025, 5:11PM Voting Results along with Scrutinizer's Report with regard to the 38th Annual General Meeting

  • IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Aug 2025, 12:41PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Transcript

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    13 Aug 2025, 12:37PM Transcript of earning call

  • IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Aug 2025, 2:55PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

  • IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Aug 2025, 2:19PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Aug 2025, 2:12PM Schedule of Analyst/Institutional Investor Meeting

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 Aug 2025, 2:10PM Schedule of Analyst/Institutional Investor Meeting

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    8 Aug 2025, 6:33PM Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1 FY2026

  • IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Aug 2025, 6:32PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Link of Recording

  • IOL Chemicals and Ph - Copy of Newspaper Publication

    8 Aug 2025, 3:28PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Investor Presentation

    7 Aug 2025, 6:43PM Investor Presentation - Q1 FY2026

  • IOL Chemicals and Ph - Investor Presentation

    7 Aug 2025, 6:42PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation

  • IOL Chemicals and Ph - Press Release

    7 Aug 2025, 6:38PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 07, 2025, titled ""Press Release Financia

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    7 Aug 2025, 6:36PM Press Release - Financial Results for the quarter ended 30th June 2025

  • IOL Chemicals and Ph - Outcome of Board Meeting

    7 Aug 2025, 2:42PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 07, 2025.

  • IOL Chemicals and Ph - Outcome of Board Meeting

    7 Aug 2025, 2:33PM IOL Chemicals and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

  • IOL Chemicals and Ph Q1 net profit up 14.42% at Rs 33.96 cr

    7 Aug 2025, 2:50PM The company reported standalone net profit of Rs 33.96 crore for the quarter ended June 30, 2025 as compared to Rs 29.68 crore in the same period last

  • IOL Chemicals and Ph - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results

    7 Aug 2025, 2:32PM Outcome of the Board Meeting and submission of Un-Audited Financial Results for the quarter ended 30th June 2025

  • IOL Chemicals and Ph - Un-Audited Financial Results For The Quarter Ended 30Th June 2025

    7 Aug 2025, 2:30PM Un-Audited Financial Results for the quarter ended 30th June 2025

  • IOL Chemicals and Ph - Updates

    5 Aug 2025, 11:38AM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 36(1)(b) of the Securities and Exchan

  • IOL Chemicals and Ph - Intimation Pursuant To Regulation 36(1)(B) Of The Securities And Exchange Board Of India (Listing Obli

    5 Aug 2025, 11:22AM Intimation pursuant to Regulation 36 (1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015

  • IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Aug 2025, 5:57PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

  • IOL Chemicals and Ph - Copy of Newspaper Publication

    4 Aug 2025, 5:51PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Aug 2025, 5:54PM Schedule of analyst / investor conference call - Q1 & FY26

  • IOL Chemicals and Ph - Copy of Newspaper Publication

    1 Aug 2025, 4:37PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

  • IOL Chemicals and Ph - Shareholders meeting

    31 Jul 2025, 2:46PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding Notice of undefined to be held on August 22, 2025

  • IOL Chemicals and Ph - Business Responsibility and Sustainability Reporting (BRSR)

    31 Jul 2025, 3:09PM Business Responsibility and Sustainability Report

  • IOL Chemicals and Ph - Reg. 34 (1) Annual Report.

    31 Jul 2025, 2:39PM Integrated Annual Report 2024-25

  • IOL Chemicals and Ph - Notice Of 38Th Annual General Meeting (AGM) Of The Company

    31 Jul 2025, 2:21PM Notice of the 38th Annual General Meeting of the Company

  • IOL Chemicals and Ph - Board Meeting Intimation for Notice Of The Board Meeting

    28 Jul 2025, 4:58PM IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia,

  • IOL Chemicals and Ph - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Jul 2025, 5:51PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

  • IOL Chemicals and Ph - Copy of Newspaper Publication

    22 Jul 2025, 5:47PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Jul 2025, 5:43PM Schedule of Analyst/Institutional Investor Meeting

  • IOL Chemicals and Ph has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 12:20PM As of June 2025, 52.62% is owned by Indian Promoters and 47.38% by Public. <p align=justify> Top four Promoters holding highest number of shares of IO

  • IOL Chemicals and Ph - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    15 Jul 2025, 5:36PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • IOL Chemicals and Ph - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Jul 2025, 5:11PM Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

  • IOL Chemicals and Ph - Credit Rating- Revision

    1 Jul 2025, 5:44PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Credit Rating- Revision

  • IOL Chemicals and Ph - Announcement under Regulation 30 (LODR)-Credit Rating

    1 Jul 2025, 5:36PM Reaffirmation of Credit Rating

  • IOL Chemicals and Ph - Trading Window-XBRL

    26 Jun 2025, 4:15PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window

  • IOL Chemicals and Ph - Trading Window

    26 Jun 2025, 4:13PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trad

  • IOL Chemicals and Ph - General Updates

    13 Jun 2025, 6:02PM IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about REACH Registration for Acetic Anhydride

  • IOL Chemicals and Ph - REACH Registration For Acetic Anhydride

    13 Jun 2025, 5:57PM REACH Registration for Acetic Anhydride

  • IOL Chemicals and Ph - General Updates

    11 Jun 2025, 5:51PM IOL Awarded EcoVadis Silver Medal - Ranks Among the Top 15% companies globally

  • IOL Chemicals and Ph - IOL Awarded Ecovadis Silver Medal - Ranks Among The Top 15% Companies Globally

    11 Jun 2025, 5:30PM IOL Awarded Ecovadis Silver Medal-Ranks Among the Top 15% companies globally

  • IOL Chemicals and Pharmaceuticals

    16 Jun 2025 , 9:19AM IOL Chemicals: The company’s product Acetic Anhydride has been registered with REACH in accordance with EU REACH regulation on chemicals and their safe use. This certification allows the company to export Acetic Anhydride across all the countries in the European Union.

  • IOL Chemicals and Pharmaceuticals

    30 Dec 2024 , 11:54AM The board approved the subdivision of each share into five.

  • IOL Chemicals

    30 May 2023 , 10:13AM Controller of Patent, Indian Patent Office, Government of India has granted on 29th May 2023 a Patent for invention entitled process for the preparation of carcinogenic azido impurities free losartan and salts thereof. Losartan is a drug used for treatment of hypertension. Positive read through for the stock.

  • IOL Chemicals gets European drug regulator nod to export Paracetamol

    8 May 2023 , 1:48PM IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to Export in European market

  • IOL Chem gets patent for preparation of Sartan drugs of Formula I

    24 Nov 2022 , 11:42AM Sartan Drugs are used to treat high blood pressure and heart failure
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of IOL Chemicals and Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1804.45 1644.09 1586.18 1433.02 1260.43
Liabilities 1804.45 1644.09 1586.18 1433.02 1260.43
Equity 58.71 58.71 58.71 58.71 58.71
Gross Profit 202.17 231.52 226.52 256.28 591.84
Net Profit 101 135.42 139.98 165.66 444.56
Cash From Operating Activities 178.68 290.76 123.14 91.04 379.78
NPM(%) 4.85 6.34 6.31 7.58 22.6
Revenue 2079.21 2132.79 2217.11 2184.02 1966.98
Expenses 1877.04 1901.27 1990.59 1927.74 1375.14
ROE(%) 6.08 8.16 8.43 9.98 26.79

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
18 Feb 2025 4 40 0.88 356.7
16 Feb 2024 5 50 0.88 443.15
17 Feb 2023 4 40 0.88 325.4
15 Feb 2022 4 40 0.88 447.9
08 Sep 2021 2 20 0.88 700.85
17 Nov 2020 4 40 0.88 691.55
18 Mar 2020 3 30 0.88 232.75

Peers

Other companies within the same industry or sector that are comparable to IOL Chemicals and Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 949.10 1.51 20.39 818.75 337.37 0.95
Amines and Plasticizers Ltd 220.92 0.89 30.56 499.31 372.61 0.23
Indogulf Cropsciences Ltd 105.57 -1.13 0.00 213.43 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 34.92 4114.71 346.70 0.43

Company Info

2003 -Shareholders approved the delisting of equity shares of the company from Ludhiana and Delhi Stock Exchanges. -Increase in Authorised Capital of the Company from Rs 150 million to Rs 200 million. 2004 -Industrial Organics Ltd has informed that after the resignation of Shri N C Gupta, Chairman cum Director, Shri Varinder Gupta, Managing Director of the Company has been appointed as Chairman of the Board of Directors. 2007 - Company name has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Ltd. 2008 -IOL Chemicals & Pharmaceuticals has been granted a Certificate of Registration by BSI Management System, for Quality Management System ISO 9001:2000 and for Environment Management System / 14001:2004 -IOL Chemicals has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. 2009 -Sh. Parminder Singh Cheema has been appointed as Nominee Director on the Board of the Company -IOL Chemicals announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, -IOL Chemicals has received DMF acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, the drug regulatory body of Canada to enable it to export ibuprofen in that country. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2009 (second rank in Drugs & Pharmaceuticals Sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources of the country. -IOL Chemicals and Pharmaceuticals felicitated by PEDA for Energy Conservation 2010 -IOL Chemicals has obtained a Certificate of Suitability for its manufacturing facilities for Ibuprofen from European Directorate for the Quality of Medicines and HealthCare. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010 2011 -IOL Chemicals's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011 2012 -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012 2013 -IOL Chemicals & Pharmaceuticals won "National Energy Conservation award (Drug and Pharma sector)2013" 2014 -IOL Chemicals & Pharmaceuticals Ltd. won "National Energy Conservation Award 2014". 2015 -IOLCP to launch API business in US market -IOL Chemicals completes De-bottlenecking project 2020 -IOL Chemicals and Pharmaceuticals Ltd got EUGMP Certification from National Institute of Pharmacy and Nutrition 2021 - IOL Chemicals and Ph Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen 2024 -Indian Chemical Council (ICC) awarded Responsible Care Logo to the Company. -IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'National Medical Products Administration (NMPA), China approves Fenofibrate manufactured by the Company.

2003 -Shareholders approved the delisting of equity shares of the company from Ludhiana and Delhi Stock Exchanges. -Increase in Authorised Capital of the Company from Rs 150 million to Rs 200 million. 2004 -Industrial Organics Ltd has informed that after the resignation of Shri N C Gupta, Chairman cum Director, Shri Varinder Gupta, Managing Director of the Company has been appointed as Chairman of the Board of Directors. 2007 - Company name has been changed from Industrial Organics Limited to IOL Chemicals and Pharmaceuticals Ltd. 2008 -IOL Chemicals & Pharmaceuticals has been granted a Certificate of Registration by BSI Management System, for Quality Management System ISO 9001:2000 and for Environment Management System / 14001:2004 -IOL Chemicals has received accreditation certificate of foreign drug manufacture from the Ministry of Health, Labor and Welfare, Yoichi Masuzoe, Japan enabling the Company to export its bulk drugs, Ibuprofen in Japan. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2008 (Second prize in chemical sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources. 2009 -Sh. Parminder Singh Cheema has been appointed as Nominee Director on the Board of the Company -IOL Chemicals announced the commencement of its manufacturing operations of Mono-chloro Acetic Acid (MCA) and Acetyl Chloride at its new manufacturing units with capacities of 7200 TPA and 5200 TPA respectively, -IOL Chemicals has received DMF acknowledgement letter for ibuprofen from Health Canada, Therapeutic Products Directorate, Canada, the drug regulatory body of Canada to enable it to export ibuprofen in that country. -IOL Chemicals has once again been awarded the most prestigious National Energy Conservation Award 2009 (second rank in Drugs & Pharmaceuticals Sector) for its ongoing efforts towards new technology implementation to conserve precious energy resources of the country. -IOL Chemicals and Pharmaceuticals felicitated by PEDA for Energy Conservation 2010 -IOL Chemicals has obtained a Certificate of Suitability for its manufacturing facilities for Ibuprofen from European Directorate for the Quality of Medicines and HealthCare. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2010 2011 -IOL Chemicals's In-House Research & Development Unit has got successfully recognition from DSIR (Deptt. of Scientific & Industrial Research), Ministry of Science & Technology, New Delhi. -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2011 2012 -IOL Chemicals & Pharmaceuticals wins National Energy Conservation Award 2012 2013 -IOL Chemicals & Pharmaceuticals won "National Energy Conservation award (Drug and Pharma sector)2013" 2014 -IOL Chemicals & Pharmaceuticals Ltd. won "National Energy Conservation Award 2014". 2015 -IOLCP to launch API business in US market -IOL Chemicals completes De-bottlenecking project 2020 -IOL Chemicals and Pharmaceuticals Ltd got EUGMP Certification from National Institute of Pharmacy and Nutrition 2021 - IOL Chemicals and Ph Approval Of Korean Ministry Of Food And Drug Safety (Korean FDA) For Company'S API Products 'Ibuprofen 2024 -Indian Chemical Council (ICC) awarded Responsible Care Logo to the Company. -IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'National Medical Products Administration (NMPA), China approves Fenofibrate manufactured by the Company.

Read More

Parent Organisation

IOL Chemicals and Pharmaceuticals Ltd.

Founded

29/09/1986

Managing Director

Mr.Varinder Gupta

NSE Symbol

IOLCPEQ

FAQ

The current price of IOL Chemicals and Pharmaceuticals Ltd is ₹ 90.74.

The 52-week high for IOL Chemicals and Pharmaceuticals Ltd is ₹ 92.80 and the 52-week low is ₹ 90.35.

The market capitalization of IOL Chemicals and Pharmaceuticals Ltd is currently ₹ 2663.47. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy IOL Chemicals and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in IOL Chemicals and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase IOL Chemicals and Pharmaceuticals Ltd shares.

The CEO of IOL Chemicals and Pharmaceuticals Ltd is Mr.Varinder Gupta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT